← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2004-12-17

Drug application

FDA Application #

ANDA065175

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

Nystatin

Active ingredients

NYSTATIN

Dosage form

POWDER

Route

TOPICAL

Marketing status

Discontinued

Sponsor

PHARMOBEDIENT

First approval

2004-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown